Questions? Call us (415) 785-3797

KAPparel

Music

Make A Donation

Funding KRF

Funding KRF

To Make a Donation please go to our Make a Donation button—thanks so much-- And here is what there is to know about us and what we are doing.

The Ketamine Research Foundation is a registered 501(c)(3).

Other than our core leadership. KRF operates with flexible staffing, building  staff as projects mature, and needs are delineated. This contributes to our ability to keep costs low and also relates to our free standing nature as a research, training and educational organization.

Donations may be earmarked for projects the donor wishes to support and otherwise will be applied at the discretion of KRF to core structural needs or to project support. Overhead is deliberately kept low to maximize the potency of donations.

Support our transformative work by making a donation. To donate via credit card or PayPal click the “Make A Donation” button 

To make a donation via check, please mail to:

The Ketamine Research Foundation
6 Crest Road
San Anselmo, CA 94960

Our Platform

  • KRF is the leading ketamine assisted psychotherapy organization in the world.
  • We have developed as a free-standing research organization, developing the options for utilizing ketamine to benefit human beings.
  • We are the preeminent training organization, having trained over 1,200 practitioners. We are producing eight or more major programs in 2025-2026. 
  • Our Ketamine Training Center is originating new programs to access KAP with our annual Advanced Sharing and our Dharma-K exploration of the integration of spirit and spiritual practices with the meditative expansiveness of the ketamine experience. Dharma K will be having its fifth annual program in May of 2027. For 2027, KTC is developing a new format for its Fundamentals programs titled The Whole K.
  • KRF is in the process of creating a unique and comprehensive APP that will provide virtually all relevant information about ketamine and KAP titled the “Keta APP.  1 ) It has 3 component parts that are addressed to the public looking for guidance in selecting a ketamine program. 2) For those people who are struggling with the potential or actuality of ketamine dependency. 3) As a full reference for practitioners, along with a CE credit opportunity. We are seeking to be the repository for addressing the full spectrum of needs for practitioners of Ketamine and KAP. 
  • Our Ketamine Psychotherapy Associates (KPA) membership organization has grown to over 180 practitioners, with new members joining frequently.
  • We remain the only organization with Access to Care available to KPA members, offering financial support to those who cannot afford treatment.
  • We are publishing our work and generating public awareness through lectures and podcasts. A chapter on KAP is included in the new Wiley handbook of psychology-forthcoming. Our clinical review of KAP adolescent psychotherapy will be published in the next few months. Recognition of KRF continues to grow.
  • In the spring of 2026 we published and circulated our second edition of the Ketamine Guidelines: also available as a Kindle book in English and Spanish. This has served as the standard in ketamine work in the field and has had massive dissemination. 
  • We have taken the lead in treating adolescents and their families. 
  • We are building an international presence in cooperation with Clinica Synaptica. Our third annual summit conference will be held this October in Barcelona. Other events are in the planning stages.

KRF’s Objectives for 2026-2027

Our Research Programs and their Funding Goals

Overview: As a free-standing research institute, we can design and conduct unique and beneficial research given ketamine’s legal status—worldwide. Developing protocols to be funded and administered under KRF’s non-profit umbrella, KRF has advantages that are creative in alleviating human suffering and engendering healing. We welcome new initiatives under our umbrella and encourage relationships with collaborating researchers. 

Each project has its own cost center, and donors to KRF may earmark their contributions. When conducting primary clinical research, KRF submits our protocols for approval to the FDA for an IND and to wcgIRB. Once approved, we delineate our projects on clinicaltrials.gov. 

Our Program Initiatives

The Phantom Limb Pain Protocol—FDA and IRB-approved. We have begun subject accrual for what we believe to be of great benefit to those suffering from the physical and emotional aftermaths of trauma and amputations. Our goal is to establish the protocol for application worldwide. 

Ketamine has indications for potential benefit for a variety of pain disorders, including phantom limb pain. Based on a compelling anecdote (our story appearing in Lucid News), we are conducting a proof-of-concept study to assess ketamine’s potential benefit for this syndrome, which causes so much suffering. 

We are pleased to report that in October of 2025, we received FDA and IRB approval for our study. The study will be conducted at 4 sites, with the goal of assessing and treating 30 patients over a 6-month period and providing a 12-month follow-up. 

$218,000 is our budget

International Protocol for Ketamine Treatment of Acute Emotional Trauma and Distress. 

In awareness of ketamine’s potential for the treatment of acute agitation, suicidality, and PTSD, and in response to the many horrors being visited on humans, we have developed ketamine protocols for the treatment of emotional reactions to acute traumatization. We have sent out our protocol as widely as possible in an effort to provide a guide to ketamine’s use as a therapeutic applicable to acute trauma. KRF serves as an initiator and a resource for practitioners. 

This is a collaboration, and to that end, we are building an international body, which we are calling the ICG, to create the conditions for applying ketamine and other modalities for acute care. This is unprecedented and has a growing literature and experience to validate our methodology. Intensive feedback from those on the ground is essential. This is a cooperative project and will grow in its scope and needs. It is created in the spirit of service and beyond borders with the intention of caring, kindness, and sharing. 

We are directly supporting trauma work with ketamine in Ukraine. Our attempt to provide trauma training with ketamine in Israel/Palestine continues—with difficulties and some success in having practitioners administer the protocol. In disaster recovery, the protocol was used following the devastating flood in North Carolina.

$35,000 is our budget 

Ketamine for Menstrually Related Disorders—PMS and PMDD

KRF is redeveloping this program as a review of the clinical application of low dose ketamine for the treatment of PMS and PMDD.We expect to begin with this patient population in the fall of 2026.

Budget to be determined

The KAP Clinical Review

As the creators and initiators of KAP, we published our study of 235 patients in 2019. It remains the cornerstone of KAP’s success story. In the intervening years, we have accumulated experience and data for over 1000 additional patients, digitized in Vanderbilt University’s REDCap program, making it highly accessible for us to publish a major new report to the field. This project entails completing the patient charts in compliance with HIPAA and, with our statistician, compiling the data and presenting it in a paper that, in great detail, reflects KAP practice.  In 2024 Wolfson and Vaid published a comprehensive review of ketamine assisted psychotherapy in the Journal of Frontiers of Psychiatry.

$75,000 is our budget

The “Keta APP” 

KRF is in the process of creating a unique and comprehensive APP that will provide virtually all relevant information about ketamine and KAP titled the “Keta APP. This is an advanced AI innovation project, interactive in nature, containing information from all of Wolfson’s work and carefully selected contributions from other practitioners, with attributions. Additionally, it contains our Ketamine Guidelines as a resource. 

The “Keta APP” will be available to all interested practitioners; licensed practitioners will have the opportunity to be listed in our referral section. Practitioners and the public who use the app will receive thorough responses based on the app’s extensive database. Information regarding specific patient issues will not be provided, as the app is not a medical provider. Access to the app for those struggling with ketamine dependency issues will be free, and modest charges to be determined will apply differentially to the other two sections. We anticipate that, over time, the “Keta App” will generate funds for KRF’s research.

$100,000 is our budget

KRF Structure and Funding Goals

  • Access to Care $100,000—available to our practitioners who are members of KPA.  See the information on the KRF site about this unique support for patients who cannot afford the KAP fees.
  • Ketamine Library, our lighthouse project containing virtually all English language references in full text—from ketamine’s inception to the present—updated and with public access, $15,000
  • The Ketamine Training Center—self-supporting. A resource now for over 8 years teaching KAP experientially to more than 1200 practitioners in the US, Canada, Israel, Malta, Spain—Catalunya—with consultation to emerging KAP practices in Australia, New Zealand, Zambia, Brazil–and more to come. We are initiating our International Psychedelic Psychotherapy Forum as a program to provide practitioners of all kinds with an ongoing interactive resource to enhance quality of care and ethical behavior.  KTC is a separate cost center, and its surpluses, when they occur, are applied to our KRF programs.
  • The BIPOC scholarship support program—in collaboration with The Trauma Research Foundation and Individual Supporters—supporting diversity in the psychedelic space— has provided BIPOC scholarships to numerous participants in our KTC programs. $25,000
  • Ketamine Psychotherapy Associates (KPA): A Program of KRF supporting KAP and KAP Practices Internationally. Supported entirely by membership fees and continually growing in numbers. We have over 180 practitioners developing their KAP programs worldwide. Included in KPA membership is the Ketamine Data Project—the seminal source for collecting and reporting data on KAP and for advancing our clinical knowledge of ketamine’s effects, problems, and outcomes.

The KAP Music Library—an expanding Playlist Library for Patient and Practitioner Use in Support of KAP sessions —continually adds new playlists and is accessible to the public at large.

Our Program

Develop, through research and clinical applications, the awareness of the potentialities and applications of ketamine for human benefit.

  • Develop and foster the treatment of acute trauma with emotional distress and potential resultant PTSD.
  • Building our teams to foster research, organization, and corporate development.
  • Funding of our programs—those in process and those emerging.
  • Foster an awareness of who we are and what we do.
  • Continue to articulate the standard of care for ketamine practices.
  • Continue to uphold the ethical practice of KAP with our Guidelines.
  • Expand and continually modify our training programs and our KPA organization.
  • Bring KAP and ketamine practice abroad with training, consultation, and support for arising practices.
  • Build coalitions with sister organizations.
  • Continue our openness to creativity, new initiatives, and development of all possible elements of KAP practice.
  • Publish a massive review of KAP practice based on our digitized REDCap program. Publish research and KAP methodology.
  • Lead the field in excellence, ethics, and standard of care.
  • Participate in the awakening to psychedelic-assisted psychotherapy.

There is much more in process, and we encourage donors to participate in our work and become familiar with what we do and who we are.

Your donations are greatly appreciated!

Hugs and love,
Phil Wolfson MD — Founder and CEO